Advertisement

cancer

Renal Cell Carcinoma Drug Gains Approval

The FDA has approved axitinib (Inlyta, Pfizer) for the treatment of advanced renal cell carcinoma (RCC). The drug is given twice daily and indicated for patients who have not responded to other RCC cancer medications. Source:...

Read More

Clinical Genomics: Moving From Bench to Bedside

More than a decade after the successful mapping of the human genome, clinical genomics is starting to permeate important parts of patient care. Studies show that about 60% of primary care physicians (PCPs) have ordered a genetic...

Read More

Managing VCFs in Cancer Patients

An international randomized control trial has found that kyphoplasty appears to be an effective and safe treatment that rapidly reduces pain and improves function for patients with cancer who have painful vertebral compression...

Read More

Management Considerations in CLL

Chronic lymphocytic leukemia (CLL) is the most common leukemia, accounting for about 15,000 new patients every year in the United States. CLL is a condition that people often live with for many years, so the prevalence is much...

Read More

Good Nutrition Critical to Chemotherapy

Great strides have been made in treating cancer to achieve a 5-year survival rate of 68%. Targeted therapies and advances in genetics are enabling more personalized patient care for several cancer types. Treating cancer patients...

Read More

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage